Terms ending in 2037
Every in-force patent on Natera, Inc.'s record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,146,195 | Methods for Lung Cancer Detection In force · High confidence | Ucl Business Ltd. | In force | High confidence | |
| US 10,533,219 | Compositions and Methods for Identifying Nucleic Acid Molecules In force · Medium confidence | Natera, Inc. | In force | Medium confidence | |
| US 10,577,650 | Compositions and Methods for Identifying Nucleic Acid Molecules In force · Medium confidence | Natera, Inc. | In force | Medium confidence | |
| US 12,460,264 | Method of Detecting Tumour Recurrence In force · High confidence | Ucl Business Ltd. | In force | High confidence | |
| US 11,319,595 | Detecting Mutations and Ploidy in Chromosomal Segments In force · High confidence | Natera, Inc. | In force | High confidence |
5 of 5 patents shown. Soonest term end first, then patent number.
3 of these are in force and held by Natera, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.